S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Baby eels remain one of America's most valuable fish after strong year in Maine
China's 1st domestically made passenger plane completes maiden commercial flight
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
'Succession' fans brace for series finale of Emmy-winning hit drama
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Voters in Turkey choose between Erdogan and Kilicdaroglu in presidential runoff
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Baby eels remain one of America's most valuable fish after strong year in Maine
China's 1st domestically made passenger plane completes maiden commercial flight
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
'Succession' fans brace for series finale of Emmy-winning hit drama
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Voters in Turkey choose between Erdogan and Kilicdaroglu in presidential runoff
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Baby eels remain one of America's most valuable fish after strong year in Maine
China's 1st domestically made passenger plane completes maiden commercial flight
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
'Succession' fans brace for series finale of Emmy-winning hit drama
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Voters in Turkey choose between Erdogan and Kilicdaroglu in presidential runoff
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Baby eels remain one of America's most valuable fish after strong year in Maine
China's 1st domestically made passenger plane completes maiden commercial flight
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
'Succession' fans brace for series finale of Emmy-winning hit drama
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Voters in Turkey choose between Erdogan and Kilicdaroglu in presidential runoff
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
NASDAQ:WBA

Walgreens Boots Alliance (WBA) Stock Forecast, Price & News

$30.01
+0.04 (+0.13%)
(As of 05/26/2023 ET)
Compare
Today's Range
$29.48
$30.13
50-Day Range
$29.97
$36.31
52-Week Range
$29.48
$44.27
Volume
7.27 million shs
Average Volume
7.49 million shs
Market Capitalization
$25.89 billion
P/E Ratio
N/A
Dividend Yield
6.40%
Price Target
$42.46

Walgreens Boots Alliance MarketRank™ Forecast

Analyst Rating
Hold
2.23 Rating Score
Upside/​Downside
41.5% Upside
$42.46 Price Target
Short Interest
Healthy
4.24% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.09
Upright™ Environmental Score
News Sentiment
0.60mentions of Walgreens Boots Alliance in the last 14 days
Based on 13 Articles This Week
Insider Trading
Acquiring Shares
$339,500 Bought Last Quarter
Proj. Earnings Growth
5.76%
From $4.51 to $4.77 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.97 out of 5 stars

Retail/Wholesale Sector

20th out of 215 stocks

Drug Stores & Proprietary Stores Industry

2nd out of 6 stocks


WBA stock logo

About Walgreens Boots Alliance (NASDAQ:WBA) Stock

Walgreens Boots Alliance Inc. is a world-renowned healthcare, pharmacy, and retailing company. Founded in 1901 by John Boot and Charles R. Walgreen, the company has grown to become a leader in the industry, operating in nine countries and providing access to healthcare services to millions of people around the world. Walgreens Boots Alliance operates through three main segments: U.S. Retail Pharmacy, International, and U.S. Healthcare.

The U.S. Retail Pharmacy segment includes the Walgreens business, which operates health and wellness services, retail drugstores, specialty and home delivery pharmacy services, and an equity method investment in AmerisourceBergen. Walgreens stores have locations in all 50 U.S. states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands, offering access to consumer goods and services, pharmacy, photo department, and health and wellness services. Walgreens also operates online stores like Walgreens.com, Drugstore.com, VisionDirect.com, and Beauty.com.

The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution company in Germany. This segment includes the Boots brand, which has a history stretching back over 170 years in the United Kingdom, and stores in Ireland and Thailand with Boots franchise operations in the Middle East and Indonesia. The remainder of the division comprises Farmacias Ahumada (FASA) pharmacies in Chile and Benavides in Mexico. The Pharmaceutical Wholesale Division, including the Alliance Healthcare brand, supplied medicines and other healthcare products to more than 115,000  doctors, health centers,  pharmacies, and hospitals annually in eleven countries through 306 distribution centers. AmerisourceBergen purchased most of the Alliance Healthcare wholesale division in June 2021 for $6.275bn in cash.

The U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omnichannel experience across the care journey. This segment includes the operation of 334 VillageMD clinics, including 146 co-located clinics, 124 standalone clinics, and 64 affiliate clinics.

Walgreens Boots Alliance produces many brands, including Soltan and Botanics, Boots Pharmaceuticals, and Boots Laboratories, No. 7, that Alliance Boots and Walgreens sought to launch internationally following the first share purchase in 2012. These brands include the famous No. 7 beauty serums, developed in Nottingham, the UVA 5-star suncare protection by Soltan, and the Botanics range, developed in partnership with the Royal Botanic Gardens, Kew. Boots' brand range includes medicines, healthcare products, skincare, and many more. Walgreens also has a self-branded line of products called "Well at Walgreens."

For the fiscal year 2020, Walgreens Boots Alliance reported earnings of US$456 million. The reported revenue was US$139.5 billion, an increase of 2.5% over the previous fiscal cycle. As of 2022, Walgreens Boots Alliance is ranked #18 on the Fortune 500 rankings. The company pays a Quarterly dividend of $0.48, representing an annual dividend yield of 5.08%. Wall Street analysts consider Walgreens stock to be Undervalued. 

Walgreens Boots Alliance has 862,503,540 shares outstanding, and its market cap is currently $31.99B. The company’s EPS estimate is $1.12, and its most recent earnings report saw it beat expectations with an EPS of $1.16. Following the earnings report, the stock price went down -6.135%. Among the most significant hedge funds holding Walgreens Boots Alliance’s shares is Antipodes Partners Ltd., which owns shares valued at $58M.

Walgreens Boots Alliance is a global healthcare leader committed to providing high-quality services and products to its customers. The company’s innovative strategies have earned it a reputation as a reliable and reputable partner for healthcare providers and consumers. With its wide array of products and services, Walgreens Boots Alliance is well-positioned to continue growing and meeting the needs of its customers for years to come.

Receive WBA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Walgreens Boots Alliance and its competitors with MarketBeat's FREE daily newsletter.

WBA Stock News Headlines

Meet the Nasdaq's 3 Biggest Dividend Payers (WBA)
Income-focused investors need not dismiss the Nasdaq as a place to find dividend-paying stocks with good growth prospects.
Is Alteryx Stock Presenting a Buying Opportunity? (WBA)
Alteryx Inc. (NYSE: AYX) is a big data analytics automation platform enabling companies to collect, process, prepare and analyze data in different formats from
Central Bank: “Final stage” beginning now
Our financial system is about to be transformed in a way that would’ve been unthinkable just a few years ago. And almost nobody is prepared for the chaos that follows.
Central Bank: “Final stage” beginning now
Our financial system is about to be transformed in a way that would’ve been unthinkable just a few years ago. And almost nobody is prepared for the chaos that follows.
Is Walgreens Boots Alliance Stock a Buy Now?
Dow Jones Today: Intel Pushes Index Higher
See More Headlines
Receive WBA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Walgreens Boots Alliance and its competitors with MarketBeat's FREE daily newsletter.

WBA Company Calendar

Ex-Dividend for 3/10 Dividend
2/15/2023
Dividend Payable
3/10/2023
Last Earnings
3/28/2023
Ex-Dividend for 6/12 Dividend
5/18/2023
Today
5/27/2023
Dividend Payable
6/12/2023
Next Earnings (Estimated)
6/29/2023
Fiscal Year End
8/31/2023

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Drug Retail
Current Symbol
NASDAQ:WBA
CUSIP
93142210
Employees
325,000
Year Founded
2014

Price Target and Rating

Average Stock Price Forecast
$42.46
High Stock Price Forecast
$54.00
Low Stock Price Forecast
$35.00
Forecasted Upside/Downside
+41.5%
Consensus Rating
Hold
Rating Score (0-4)
2.23
Research Coverage
13 Analysts

Profitability

Net Income
$4.34 billion
Pretax Margin
-4.08%

Debt

Sales & Book Value

Annual Sales
$132.70 billion
Cash Flow
$7.36 per share
Book Value
$33.98 per share

Miscellaneous

Free Float
711,807,000
Market Cap
$25.89 billion
Optionable
Optionable
Beta
0.71

Social Links


Key Executives

  • Rosalind Gates Brewer
    Chief Executive Officer & Director
  • Ornella BarraOrnella Barra
    Chief Operating Officer-International
  • James Kehoe
    Global Chief Financial Officer & Executive VP
  • Kevin M. Ban
    Global Chief Medical Officer & Executive VP
  • Hsiao Wang
    Chief Information Officer & Senior Vice President













WBA Stock - Frequently Asked Questions

Should I buy or sell Walgreens Boots Alliance stock right now?

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last year. There are currently 1 sell rating, 8 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" WBA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WBA, but not buy additional shares or sell existing shares.
View WBA analyst ratings
or view top-rated stocks.

What is Walgreens Boots Alliance's stock price forecast for 2023?

13 analysts have issued 12 month target prices for Walgreens Boots Alliance's shares. Their WBA share price forecasts range from $35.00 to $54.00. On average, they predict the company's share price to reach $42.46 in the next year. This suggests a possible upside of 41.5% from the stock's current price.
View analysts price targets for WBA
or view top-rated stocks among Wall Street analysts.

How have WBA shares performed in 2023?

Walgreens Boots Alliance's stock was trading at $37.36 at the beginning of 2023. Since then, WBA stock has decreased by 19.7% and is now trading at $30.01.
View the best growth stocks for 2023 here
.

When is Walgreens Boots Alliance's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 29th 2023.
View our WBA earnings forecast
.

How were Walgreens Boots Alliance's earnings last quarter?

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) issued its quarterly earnings results on Tuesday, March, 28th. The pharmacy operator reported $1.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.10 by $0.06. The pharmacy operator earned $34.86 billion during the quarter, compared to analyst estimates of $33.56 billion. Walgreens Boots Alliance had a positive trailing twelve-month return on equity of 12.42% and a negative net margin of 2.36%. The firm's quarterly revenue was up 3.3% on a year-over-year basis. During the same period in the prior year, the firm posted $1.59 earnings per share.
Read the conference call transcript
.

How often does Walgreens Boots Alliance pay dividends? What is the dividend yield for Walgreens Boots Alliance?

Walgreens Boots Alliance announced a quarterly dividend on Thursday, April 20th. Stockholders of record on Friday, May 19th will be given a dividend of $0.48 per share on Monday, June 12th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 6.40%. The ex-dividend date is Thursday, May 18th.
Read our dividend analysis for WBA
.

Is Walgreens Boots Alliance a good dividend stock?

Walgreens Boots Alliance (NASDAQ:WBA) pays an annual dividend of $1.92 per share and currently has a dividend yield of 6.41%. WBA has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for WBA.

What guidance has Walgreens Boots Alliance issued on next quarter's earnings?

Walgreens Boots Alliance issued an update on its FY 2023 earnings guidance on Wednesday, March, 29th. The company provided EPS guidance of $4.45-$4.65 for the period, compared to the consensus estimate of $4.51. The company issued revenue guidance of -.

What is Stefano Pessina's approval rating as Walgreens Boots Alliance's CEO?

4,267 employees have rated Walgreens Boots Alliance Chief Executive Officer Stefano Pessina on Glassdoor.com. Stefano Pessina has an approval rating of 32% among the company's employees. This puts Stefano Pessina in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Walgreens Boots Alliance own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Walgreens Boots Alliance investors own include AT&T (T), Intel (INTC), CVS Health (CVS), Johnson & Johnson (JNJ), Walt Disney (DIS), Cisco Systems (CSCO), AbbVie (ABBV), Verizon Communications (VZ), Pfizer (PFE) and Exxon Mobil (XOM).

What is Walgreens Boots Alliance's stock symbol?

Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."

Who are Walgreens Boots Alliance's major shareholders?

Walgreens Boots Alliance's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.35%), State Street Corp (6.45%), FMR LLC (1.59%), Geode Capital Management LLC (1.56%), Federated Hermes Inc. (1.01%) and Bank of New York Mellon Corp (0.79%). Insiders that own company stock include Kevin M Ban, Marco Patrick Anthony Pagni, Nancy M Schlichting, Rosalind G Brewer and Walgreens Boots Alliance, Inc.
View institutional ownership trends
.

How do I buy shares of Walgreens Boots Alliance?

Shares of WBA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Walgreens Boots Alliance's stock price today?

One share of WBA stock can currently be purchased for approximately $30.01.

How much money does Walgreens Boots Alliance make?

Walgreens Boots Alliance (NASDAQ:WBA) has a market capitalization of $25.89 billion and generates $132.70 billion in revenue each year. The pharmacy operator earns $4.34 billion in net income (profit) each year or ($3.65) on an earnings per share basis.

How many employees does Walgreens Boots Alliance have?

The company employs 325,000 workers across the globe.

Does Walgreens Boots Alliance have any subsidiaries?
The following companies are subsidiares of Walgreens Boots Alliance: Alliance Boots Holdings Limited, Alliance Healthcare Deutschland AG, Bond Drug Company of Illinois LLC, Boots Opticians Professional Services Limited, Boots Properties Limited, Boots Property Partnerships, Boots Retail (Ireland) Limited, Boots Retail (Thailand) Limited, Boots UK Limited, Duane Reade, Farmacias Benavides S.A.B. de C.V., Innovation Associates Inc, Liz Earle Beauty, Prime Therapeutics Specialty Pharmacy LLC, Shields Health Solutions, Sinopharm Holding GuoDa Drug Store Co., Superior Acquisitions Limited, Superior Holdings Limited, Superior Luxco 1 S.à r.l., Take Care Health Employer Solutions, The Boots Company PLC, WBA Acquisitions UK Holdco 7 Limited, WBA Acquisitions UK Topco Limited, WBA Financial LLC, WBA International Limited, WBA Investments Inc., WBA Luxembourg 6 S.à r.l., WBA Luxembourg 7 S.à.r.l., WBAD Holdings Limited, Walgreen Arizona Drug Co., Walgreen Co., Walgreen Eastern Co. Inc., Walgreen International S.à r.l., Walgreen Investments Luxembourg S.à r.l., Walgreen Louisiana Co. Inc., Walgreen of Puerto Rico Inc., Walgreens Boots Alliance (Hong Kong) Investments Limited, Walgreens Boots Alliance Holdings LLC, Walgreens Boots Alliance Limited, Walgreens Specialty Pharmacy LLC, and Waltrust Properties Inc..
Read More
How can I contact Walgreens Boots Alliance?

Walgreens Boots Alliance's mailing address is 108 Wilmot Road, Deerfield IL, 60015. The official website for the company is www.walgreensbootsalliance.com. The pharmacy operator can be reached via phone at (847) 315-3700, via email at investor.relations@wba.com, or via fax at 847-914-2804.

This page (NASDAQ:WBA) was last updated on 5/28/2023 by MarketBeat.com Staff

My Account -